Enanta Pharmaceuticals Inc. | Key People and Executives
Jay R. Luly
President, Chief Executive Officer & Director
Kristine Peterson
Director
Bruce Leonard Andrews Carter
Non-Executive Chairman
George S. Golumbeski
Independent Director
Stephen Buckley
Independent Director
Terry C. Vance
Lead Independent Director
Lesley Russell
Independent Director
Jay R. Luly
President, Chief Executive Officer & Director
Paul J. Mellett
CFO, Principal Accounting Officer & SVP-Finance
Yat Sun Or
CSO, Senior Vice President-Research & Development
Nathalie Adda
Chief Medical Officer & Senior Vice President
Timothy D. Ocain
Senior VP-New Product Strategy & Development
Kristine Peterson
Director
Carol Miceli
Director-Investor Relations
Nathaniel S. Gardiner
Senior Vice President & General Counsel
Bruce Leonard Andrews Carter
Non-Executive Chairman
George S. Golumbeski
Independent Director
Stephen Buckley
Independent Director
Terry C. Vance
Lead Independent Director
Lesley Russell
Independent Director
| Address |
500 Arsenal Street
Watertown Massachusetts 02472
United States
|
|
Employees
|
- |
| Website |
http://www.enanta.com |
| Updated |
07/08/2019 |
| Enanta Pharmaceuticals, Inc. engages in the research and development of small molecule drugs for the treatment of viral infections and liver diseases. It offers the two protease inhibitors Maviret and the Viekira Pak for the treatment of chronic hepatitis C virus. The company was founded by Peter O. |
